GrantExec

Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)

This funding opportunity supports early-stage research to develop new therapeutic agents for heart, lung, blood, and sleep disorders, specifically targeting projects that have identified promising small molecules or biologics ready for preclinical testing.

$350,000
Closed
Nationwide
Key Dates

Application Opens

January 24, 2022

Application Closes

November 21, 2024

Contact Information

Grantor

NIH OER Webmaster

Subscribe to view contact details

Newsletter Required
Categories
Health